References
- American Cancer Society. Cancer Facts & Figures 2020. Atlanta (GA): American Cancer Society; 2020.
- Li W, Zhang X, Sang H, Zhou Y, Shang C, Wang Y, Zhu H. Effects of hyperglycemia on the progression of tumor diseases. J Exp Clin Cancer Res. 2019;38(1):327. doi:https://doi.org/10.1186/s13046-019-1309-6
- Lega IC, Austin PC, Fischer HD, Fung K, Krzyzanowska MK, Amir E, Lipscombe LL. The impact of diabetes on breast cancer treatments and outcomes: a population-based study. Diabetes Care. 2018;41(4):755–761. doi:https://doi.org/10.2337/dc17-2012
- Millikan RC, Newman B, Tse C-K, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008;109(1):123–139. doi:https://doi.org/10.1007/s10549-007-9632-6
- Hou Y, Zhou M, Xie J, Chao P, Feng Q, Wu J. High glucose levels promote the proliferation of breast cancer cells through GTPases. Breast Cancer (Dove Med Press). 2017;9:429–436. doi:https://doi.org/10.2147/BCTT.S135665
- Lopez R, Arumugam A, Joseph R, Monga K, Boopalan T, Agullo P, Gutierrez C, Nandy S, Subramani R, de la Rosa JM, et al. Hyperglycemia enhances the proliferation of non-tumorigenic and malignant mammary epithelial cells through increased leptin/IGF1R signaling and activation of AKT/mTOR. PloS One. 2013;8(11):e79708. doi:https://doi.org/10.1371/journal.pone.0079708
- Sun S, Sun Y, Rong X, Bai L. High glucose promotes breast cancer proliferation and metastasis by impairing angiotensinogen expression. Biosci Rep. 2019;39.
- Ntwasa M, Njende U. Glucose metabolism and carcinogenesis: the impact of the tumor suppressor p53. Neoplasm. 2018;109-136.
- Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi:https://doi.org/10.1126/science.123.3191.309
- McCleland ML, Adler AS, Shang Y, Hunsaker T, Truong T, Peterson D, Torres E, Li L, Haley B, Stephan JP, et al. An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer. Cancer Res. 2012;72(22):5812–5823. doi:https://doi.org/10.1158/0008-5472.CAN-12-1098
- Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM, Karagiannis TC. Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep. 2015;42(4):841–851. doi:https://doi.org/10.1007/s11033-015-3858-x
- Patra KC, Wang Q, Bhaskar PT, Miller L, Wang Z, Wheaton W, Chandel N, Laakso M, Muller WJ, Allen EL, et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell. 2013;24(2):213–228. doi:https://doi.org/10.1016/j.ccr.2013.06.014
- Luo F, Li Y, Yuan F, Zuo J. Hexokinase II promotes the Warburg effect by phosphorylating alpha subunit of pyruvate dehydrogenase. Chin J Cancer Res. 2019;31(3):521–532. doi:https://doi.org/10.21147/j.issn.1000-9604.2019.03.14
- Roberts DJ, Miyamoto S. Hexokinase II integrates energy metabolism and cellular protection: akting on mitochondria and TORCing to autophagy. Cell Death Differ. 2015;22(2):364. doi:https://doi.org/10.1038/cdd.2014.208
- Barbara S, Alberto Del R, Cecilia M, Gianmario S, Renzo C, Davide M. Metformin, cancer and glucose metabolism. Endocr-Ret Cancer. 2014;21(6):R461–R471. doi:https://doi.org/10.1530/ERC-14-0284
- Wei L, Zhou Y, Dai Q, Qiao C, Zhao L, Hui H, Lu N, Guo QL. Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma. Cell Death Dis. 2013;4:e601. doi:https://doi.org/10.1038/cddis.2013.131
- Kerr RG, Chen Z. In vivo and in vitro biosynthesis of saponins in sea cucumbers. J Nat Prod. 1995;58(2):172–176. doi:https://doi.org/10.1021/np50116a002
- Aminin DL, Chaykina EL, Agafonova IG, Avilov SA, Kalinin VI, Stonik VA. Antitumor activity of the immunomodulatory lead Cumaside. Int Immunopharmacol. 2010;10(6):648–654. doi:https://doi.org/10.1016/j.intimp.2010.03.003
- Goad LJ, Garneau FX, Simard JL, ApSimon JW, Girard M. Isolation ofΔ9(11)-sterols from the sea cucumber psolusfabricii. implications for holothurin biosynthesis. Tetrahedron Lett. 1985;26(29):3513–3516. doi:https://doi.org/10.1016/S0040-4039(00)98678-7
- Mamelona J, Pelletier É, Girard-Lalancette K, Legault J, Karboune S, Kermasha S. Quantification of phenolic contents and antioxidant capacity of Atlantic sea cucumber, Cucumaria frondosa. Food Chem. 2007;104(3):1040–1047. doi:https://doi.org/10.1016/j.foodchem.2007.01.016
- Nagase H, Enjyoji K-i, Minamiguchi K, Kitazato KT, Kitazato K, Saito H, Kato H. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III-and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin. Blood. 1995;85(6):1527–1534. doi:https://doi.org/10.1182/blood.V85.6.1527.bloodjournal8561527
- Omran NE, Khedr AM. Structure elucidation, protein profile and the antitumor effect of the biological active substance extracted from sea cucumber Holothuria polii. Toxicol Ind Health. 2015;31(1):1–8. doi:https://doi.org/10.1177/0748233712466135
- Kim SK, Himaya SW. Triterpene glycosides from sea cucumbers and their biological activities. Adv Food Nutr Res. 2012;65:297–319. doi:https://doi.org/10.1016/B978-0-12-416003-3.00020-2
- Janakiram NB, Mohammed A, Rao CV. Sea cucumbers metabolites as potent anti-cancer agents. Mar Drugs. 2015;13(5):2909–2923. doi:https://doi.org/10.3390/md13052909
- Sangpairoj K, Chaithirayanon K, Vivithanaporn P, Siangcham T, Jattujan P, Poomtong T, Nobsathian S, Sobhon P. Extract of the sea cucumber, Holothuria scabra, induces apoptosis in human glioblastoma cell lines. Funct Food Health Dis. 2016;452–468.
- Yu S, Ye X, Huang H, Peng R, Su Z, Lian XY, Zhang Z. Bioactive sulfated saponins from sea cucumber Holothuria moebii. Planta Med. 2015;81(2):152–159. doi:https://doi.org/10.1055/s-0034-1383404
- Zordoky BNM, Bark D, Soltys CL, Sung MM, Dyck JRB. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention. Biochim Biophys Acta. 2014;1840(6):1943–1957. doi:https://doi.org/10.1016/j.bbagen.2014.01.023
- Althunibat OY, Hashim RB, Taher M, Daud JM, Ikeda M-A, Zali BI. In vitro antioxidant and antiproliferative activities of three Malaysian sea cucumber species. Eur J Sci Res. 2009;37:376–387.
- Bordbar S, Anwar F, Saari N. High-value components and bioactives from sea cucumbers for functional foods – a review. Mar Drugs. 2011;9(10):1761–805. doi:https://doi.org/10.3390/md9101761
- Ogushi M, Yoshie-Stark Y, Suzuki T. Cytostatic activity of hot water extracts from the sea cucumber in Caco-2. FSTR. 2005;11(2):202–206. doi:https://doi.org/10.3136/fstr.11.202
- Koczurkiewicz P, Czyż J, Podolak I, Wójcik K, Galanty A, Janeczko Z, Michalik M. Multidirectional effects of triterpene saponins on cancer cells – mini-review of in vitro studies. Acta Biochim Pol. 2015;62(3):383–393. doi:https://doi.org/10.18388/abp.2015_1089
- Chen AY, Chen YC. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem. 2013;138(4):2099–2107. doi:https://doi.org/10.1016/j.foodchem.2012.11.139
- Santhanam RK, Ahmad S, Abas F, Safinar Ismail I, Rukayadi Y, Tayyab Akhtar M, Shaari K. Bioactive constituents of Zanthoxylum rhetsa bark and its cytotoxic potential against B16-F10 melanoma cancer and normal human dermal fibroblast (HDF) cell lines. Molecules. 2016;21(6):652. doi:https://doi.org/10.3390/molecules21060652
- Attoub S, Arafat K, Gélaude A, Al Sultan MA, Bracke M, Collin P, Takahashi T, Adrian TE, De Wever O. Frondoside A Suppressive Effects on Lung Cancer Survival, Tumor Growth, Angiogenesis, Invasion, and Metastasis. PLOS One. 2013;8(1):e53087. doi:https://doi.org/10.1371/journal.pone.0053087
- Duan W, Shen X, Lei J, Xu Q, Yu Y, Li R, Wu E, Ma Q. Hyperglycemia, a neglected factor during cancer progression. Biomed Res Int. 2014;2014:461917. doi:https://doi.org/10.1155/2014/461917
- Takatani-Nakase T, Matsui C, Maeda S, Kawahara S, Takahashi K. High glucose level promotes migration behavior of breast cancer cells through zinc and its transporters. PLOS One. 2014;9(2):e90136. doi:https://doi.org/10.1371/journal.pone.0090136
- Laudański P, Swiatecka J, Kovalchuk O, Wołczyński S. Expression of GLUT1 gene in breast cancer cell lines MCF-7 and MDA-MB-231. Ginekol Pol. 2003;74(9):782–785.
- Miao G, Han J, Zhang J, Wu Y, Tong G. Targeting pyruvate kinase M2 and hexokinase II, pachymic acid impairs glucose metabolism and induces mitochondrial apoptosis. Biol Pharm Bull. 2019;42(1):123–129. doi:https://doi.org/10.1248/bpb.b18-00730
- Mazure N. VDAC in cancer. Biochim Biophys Acta Bioenerg. 2017;1858(8):665–673. doi:https://doi.org/10.1016/j.bbabio.2017.03.002
- Abotaleb M, Samuel SM, Varghese E, Varghese S, Kubatka P, Liskova A, Büsselberg D. Flavonoids in cancer and apoptosis. Cancers. 2018;11(1):28. doi:https://doi.org/10.3390/cancers11010028
- Revathidevi S, Munirajan AK. Akt in cancer: mediator and more. Semin Cancer Biol. 2019;59:80–91. doi:https://doi.org/10.1016/j.semcancer.2019.06.002
- Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, Fairley LL, Boniol M, Zheng T, Zhang Y, et al. Diabetes and breast cancer risk: a meta-analysis. Br J Cancer. 2012;107(9):1608–1617. doi:https://doi.org/10.1038/bjc.2012.414
- Cantor JR, Sabatini DM. Cancer cell metabolism: one hallmark, many faces. Cancer Discov. 2012;2(10):881–898. doi:https://doi.org/10.1158/2159-8290.CD-12-0345
- Sato-Tadano A, Suzuki T, Amari M, Takagi K, Miki Y, Tamaki K, Watanabe M, Ishida T, Sasano H, Ohuchi N. Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67. Cancer Sci. 2013;104(10):1380–1388. doi:https://doi.org/10.1111/cas.12238
- Siddiqui FA, Prakasam G, Chattopadhyay S, Rehman AU, Padder RA, Ansari MA, Irshad R, Mangalhara K, Bamezai RNK, Husain M, Ali SM, et al. Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition. Sci Rep. 2018;8(1):8323. doi:https://doi.org/10.1038/s41598-018-25524-3
- Oberhammer FA, Hochegger K, Fröschl G, Tiefenbacher R, Pavelka M. Chromatin condensation during apoptosis is accompanied by degradation of lamin A + B, without enhanced activation of cdc2 kinase. J Cell Biol. 1994;126(4):827–837. doi:https://doi.org/10.1083/jcb.126.4.827
- Zheng H-C. The molecular mechanisms of chemoresistance in cancers. Oncotarget. 2017;8(35):59950–59964. doi:https://doi.org/10.18632/oncotarget.19048
- Chang F, Lee J, Navolanic P, Steelman L, Shelton J, Blalock W, Franklin R, McCubrey J. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia. 2003;17(3):590–603. doi:https://doi.org/10.1038/sj.leu.2402824
- Al Marzouqi N, Iratni R, Nemmar A, Arafat K, Al Sultan MA, Yasin J, Collin P, Mester J, Adrian TE, Attoub S. Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts. Eur J Pharmacol. 2011;668(1–2):25–34. doi:https://doi.org/10.1016/j.ejphar.2011.06.023
- Li X, Roginsky AB, Ding XZ, Woodward C, Collin P, Newman RA, Bell RH, Jr., Adrian TE. Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, Frondoside A. Ann N Y Acad Sci. 2008;1138:181–198. doi:https://doi.org/10.1196/annals.1414.025
- Attoub S, Arafat K, Khalaf T, Sulaiman S, Iratni R. Frondoside A enhances the anti-cancer effects of oxaliplatin and 5-fluorouracil on colon cancer cells. Nutrients. 2018;10(5):560. doi:https://doi.org/10.3390/nu10050560